We created Malcova to see deeper and clearer from the start—so life-threatening conditions like cancers in dense breast tissue and acute strokes are detected early, accurately, and with confidence.
Founded by experts Dr. Tara Ghazi and Dr. Peymon Ghazi, Malcova was born from the urgent need for better early disease detection. Our patented Narrow-Beam CT, digital twins, and physical twins technologies have moved from visionary ideas to powerful solutions, positioning us as disruptors in medical imaging.
We are driven by science, empowered by innovation, and committed to transforming patient care.
End misdiagnosis by delivering imaging that sees deeper, sooner—and safer.
A world where everyone benefits from early, accurate, non-invasive diagnostics.
We’re committed to improving lives. Our technology promises early and accurate disease detection without pain or unnecessary radiation, giving patients peace of mind and healthcare providers pride in their care.
At Malcova, deep scientific rigor is our foundation. Our patented Narrow-Beam CT, and our digital and physical "twins" are meticulously engineered to provide unparalleled diagnostic clarity and efficacy.
We don’t follow trends—we set them. Our cutting-edge imaging technologgy delivers superior accuracy, comfort, and safety, fundamentally changing how disease will be diagnosed.
Co-Founder & CBO
Dr. Tara Ghazi
Co-Founder & CEO
Dr. Peymon Ghazi
Head of Hardware
Michael Kim
Head of Software
Dr. Jason Lomnitz
"We founded Malcova to ensure that all women have access to safe, comfortable and clinically effective imaging."
Stay informed with the latest breakthroughs, research, and industry insights on dense breast imaging and early detection challenges. Explore how innovation is shaping the future of radiology.
MALCOVA is the proud recipient of funding from the United States Federal government through the National Science Foundation and the National Institute of Health.
Our Financial Conflict of Interest (FCOI) Management policy can be found HERE.
